致心律失常性右心室心肌病的个体化家族筛查
该研究纳入荷兰ARVC注册中136名无明确ARVC的亲属,随访8.1年后33%发展为明确ARVC;症状、20-30岁年龄及基线临界ARVC是独立预测因素,临界者1年进展概率13%远高于可能者的0.6%,提示可按风险分层调整随访频率。
要点
- 症状、20-30岁及基线临界ARVC的亲属进展为明确ARVC风险更高。
- 临界ARVC者1年进展概率13%,显著高于可能者的0.6%。
- 低风险亲属可减少随访频率,高风险者需更密切监测。
核心结论
- 有症状、20-30岁及基线临界ARVC的亲属进展为明确ARVC概率更高,可据此个体化随访。
研究设计与样本
- 荷兰ARVC注册中136名无明确ARVC的亲属(46%男性,中位年龄25.5岁)的前瞻性队列研究,并用意大利队列(57%男性,中位年龄37.0岁)外部验证。
主要发现
- 中位随访8.1年后,123名有随访的亲属中41名(33%)发展为明确ARVC。
- 有症状者(P=0.014)和20-30岁者(P=0.002)进展为明确ARVC的风险更高,独立于基线表型。
- 临界ARVC者进展为明确ARVC的概率高于可能者:1年概率13% vs 0.6%,3年概率35% vs 5%(P<0.01)。
- 外部验证结果可比(P>0.05)。
关键数值与推荐
- 基线临界ARVC定义为1项次要Task Force标准加遗传或家族易感,可能ARVC仅遗传或家族易感。
- 临界ARVC者1年进展概率13%,3年35%;可能ARVC者1年0.6%,3年5%。
临床怎么用
- 对无症状且无其他危险因素的年轻亲属可考虑降低随访频率,对有症状、20-30岁或临界ARVC者加强监测。
局限性
- 原文未报告
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Clinical guidelines recommend regular screening for arrhythmogenic right ventricular cardiomyopathy (ARVC) to monitor at-risk relatives, resulting in a significant burden on clinical resources. Prioritizing relatives on their probability of developing definite ARVC may provide more efficient patient care. OBJECTIVES: The aim of this study was to determine the predictors and probability of ARVC development over time among at-risk relatives. METHODS: A total of 136 relatives (46% men, median age 25.5 years [IQR: 15.8-44.4 years]) from the Netherlands Arrhythmogenic Cardiomyopathy Registry without definite ARVC by 2010 task force criteria were included. Phenotype was ascertained using electrocardiography, Holter monitoring, and cardiac imaging. Subjects were divided into groups with "possible ARVC" (only genetic or familial predisposition) and "borderline ARVC" (1 minor task force criterion plus genetic or familial predisposition). Cox regression was performed to determine predictors and multistate modeling to assess the probability of ARVC development. Results were replicated in an unrelated Italian cohort (57% men, median age 37.0 years [IQR: 25.4-50.4 years]). RESULTS: At baseline, 93 subjects (68%) had possible ARVC, and 43 (32%) had borderline ARVC. Follow-up was available for 123 relatives (90%). After 8.1 years (IQR: 4.2-11.4 years), 41 (33%) had developed definite ARVC. Independent of baseline phenotype, symptomatic subjects (P = 0.014) and those 20 to 30 years of age (P = 0.002) had a higher hazard of developing definite ARVC. Furthermore, patients with borderline ARVC had a higher probability of developing definite ARVC compared with those with possible ARVC (1-year probability 13% vs 0.6%, 3-year probability 35% vs 5%; P < 0.01). External replication showed comparable results (P > 0.05). CONCLUSIONS: Symptomatic relatives, those 20 to 30 years of age, and those with borderline ARVC have a higher probability of developing definite ARVC. These patients may benefit from more frequent follow-up, while others may be monitored less often.
引用
- Muller SA, Gasperetti A, Bosman LP, et al. Individualized Family Screening for Arrhythmogenic Right Ventricular Cardiomyopathy. J Am Coll Cardiol. 2023. PMID: 37210036. doi:10.1016/j.jacc.2023.05.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。